Skip to main content
SpringerLink
Log in

Superior Survival in Treatment of Primary Nonmetastatic Pediatric Osteosarcoma of the Extremity

  • New Approaches to the Treatment of Hepatic Malignancies
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background: A protocol to treat osteosarcoma of the extremity was developed at two local institutions.

Methods: The study involved a dose-intensified neoadjuvant protocol of intravenous doxorubicin and intra-arterial cisplatin administered repetitively until maximum angiographic response was noted. Definitive surgery was delayed until ≥90% reduction in tumor neovascularity was documented. Prospective assessment of serial arteriograms was highly accurate (94%) in predicting histological response and assisted in surgical planning. After resection, if patients were determined to be good responders (≥90% tumor necrosis), they underwent a 4-month postoperative course with the same agents. Poor responders (<90% necrosis) were treated with alternative agents for 12 months from diagnosis. Forty-seven assessable patients with primary, high-grade, nonmetastatic osteosarcoma of the extremity were included in this analysis. The median age was 15 years (range, 7–21 years).

Results: Patients underwent an average of four preoperative intra-arterial courses. Forty-three patients underwent limb-preservation procedures, and 41 had >90% tumor necrosis. With an average follow-up of 92 months (range, 20–178 months), 39 patients were continuously disease free, 3 died of disease, 1 died of other causes, and 4 have no evidence of disease 11 to 51 months after relapse (all pulmonary metastases). There were no local recurrences. Kaplan-Meier analysis demonstrated a 10-year overall survival of 92% and an event-free survival of 84%.

Conclusions: This study demonstrates excellent survival with a dose-intensified neoadjuvant protocol. Future endeavors should involve a multi-institutional randomized study comparing this approach with another multiagent intravenous neoadjuvant protocol.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Bacci G, Ferrari S, Bertoni F, et al. Long-term outcome for patients with nonmetastatic osteosarcoma of the extremity treated at the istituto ortopedico rizzoli according to the istituto ortopedico rizzoli/osteosarcoma-2 protocol: an updated report. J Clin Oncol 2000; 18: 4016–27.

    PubMed  CAS  Google Scholar 

  2. Brosjo O. Surgical procedure and local recurrence in 224 patients treated 1982–1997 according to two osteosarcoma chemotherapy protocols. The Scandinavian Sarcoma Group experience. Acta Orthop Scand Suppl 1999; 285: 58–61.

    PubMed  CAS  Google Scholar 

  3. Ettinger LJ, Douglass HO, Higby DJ, et al. Adjuvant adriamycin and cis-diamminedichloroplatinum (cis-platinum) in primary osteosarcoma. Cancer 1981; 47: 248–54.

    PubMed  CAS  Google Scholar 

  4. Ferrari S, Bacci G, Picci P, et al. Long-term follow-up and post-relapse survival in patients with non-metastatic osteosarcoma of the extremity treated with neoadjuvant chemotherapy. Ann Oncol 1997; 8: 765–71.

    PubMed  CAS  Google Scholar 

  5. Fuchs N, Bielack SS, Epler D, et al. Long-term results of the co-operative German-Austrian-Swiss osteosarcoma study group’s protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs. Ann Oncol 1998; 9: 893–9.

    Article  CAS  PubMed  Google Scholar 

  6. Honegger HP, Cserhati MD, Exner GU, von Hochstetter A, Groscurth P. Zurich experience with preoperative, high dose methotrexate-containing chemotherapy in patients with extremity osteosarcomas (OSA). Ann Oncol 1991; 2: 489–94.

    PubMed  CAS  Google Scholar 

  7. Marcove RC, Mike V, Hajek JV, Levin AG, Hutter RV. Osteogenic sarcoma under the age of twenty-one. A review of one hundred and forty-five operative cases. J Bone Joint Surg Am 1970; 52: 411–23.

    PubMed  CAS  Google Scholar 

  8. Mercuri M, Capanna R, Manfrini M, et al. The management of malignant bone tumors in children and adolescents. Clin Orthop 1991; 264: 156–68.

    PubMed  Google Scholar 

  9. Pathak AB, Advani SH, Lyer RS, et al. Adjuvant chemotherapy for osteogenic sarcoma of the extremity with sequential adriamycin and cisplatin. J Surg Oncol 1993; 52: 181–4.

    PubMed  CAS  Google Scholar 

  10. Philip T, Iliescu C, Demaille MC, et al. High-dose methotrexate and HELP [Holoxan (ifosfamide), eldesine (vindesine), platinum]–doxorubicin in non-metastatic osteosarcoma of the extremity: a French multicentre pilot study. Federation Nationale des Centres de Lutte contre le Cancer and Societe Francaise d’Oncologie Pediatrique. Ann Oncol 1999; 10: 1065–71.

    PubMed  CAS  Google Scholar 

  11. Provisor AJ, Ettinger LJ, Nachman JB, et al. Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children’s Cancer Group. J Clin Oncol 1997; 15: 76–84.

    PubMed  CAS  Google Scholar 

  12. Cara JA, Canadell J. Limb salvage for malignant bone tumors in young children. J Pediatr Orthop 1994; 14: 112–8.

    PubMed  CAS  Google Scholar 

  13. Souhami RL, Craft AW, Van der Eijken JW, et al. Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup. Lancet 1997; 350: 911–7.

    PubMed  CAS  Google Scholar 

  14. Uchida A, Myoui A, Araki N, Yoshikawa H, Shinto Y, Ueda T. Neoadjuvant chemotherapy for pediatric osteosarcoma patients. Cancer 1997; 79: 411–5.

    PubMed  CAS  Google Scholar 

  15. Stewart DJ, Benjamin RS, Zimerman S, et al. Clinical pharmacology of intraarterial cis-diamminedichloroplatinum (II). Cancer Res 1983; 43: 917–20.

    PubMed  CAS  Google Scholar 

  16. Carrasco CH, Charnsangavej C, Raymond AK, et al. Osteosarcoma: angiographic assessment of response to preoperative chemotherapy. Radiology 1989; 170: 839–42.

    PubMed  CAS  Google Scholar 

  17. Huvos AG, Rosen G, Marcove RC. Primary osteogenic sarcoma: pathologic aspects in 10 patients after treatment with chemotherapy, en bloc resection, and prosthetic bone replacement. Arch Pathol Lab Med 1977; 101: 14–8.

    PubMed  CAS  Google Scholar 

  18. Enneking WF. A system for the functional evaluation of the surgical management of musculoskeletal tumors. In: Enneking WF, ed. Limb Salvage in Musculoskeletal Oncology. New York: Churchill Livingstone, 1987: 5–16.

    Google Scholar 

  19. Enneking WF, Dunham W, Gebhardt MC, Malawar M, Pritchard D. A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system. Clin Orthop 1993; 286: 241–6.

    PubMed  Google Scholar 

  20. Wilkins RM, Soubeiran A. The Phenix expandable prosthesis: early American experience. Clin Orthop 2001; 382: 51–8.

    PubMed  Google Scholar 

  21. Bacci G, Ferrari S, Longhi A, et al. Neoadjuvant chemotherapy for high grade osteosarcoma of the extremities: long-term results for patients treated according to the Rizzoli IOR/OS-3b protocol. J Chemother 2001; 13: 93–9.

    PubMed  CAS  Google Scholar 

  22. Bacci G, Ferrari S, Mercuri M, et al. Predictive factors for local recurrence in osteosarcoma: 540 patients with extremity tumors followed for minimum 2.5 years after neoadjuvant chemotherapy. Acta Orthop Scand 1998; 69: 230–6.

    Article  PubMed  CAS  Google Scholar 

  23. Jaffe N, Knapp J, Chuang V, et al. Osteosarcoma: intra-arterial treatment of the primary tumor with cis-diamminedichloroplatinum II (CDP); angiographic, pathologic, and pharmacologic studies. Cancer 1983; 51: 402–7.

    CAS  PubMed  Google Scholar 

  24. Jaffe N, Raymond K, Ayala A, et al. Effect of cumulative courses of intraarterial cis-diamminedichloroplatin-II on the primary tumor in osteosarcoma. Cancer 1989; 63: 63–7.

    PubMed  CAS  Google Scholar 

  25. Bacci G, Ferrari S, Tienghi A, et al. A comparison of methods of loco-regional chemotherapy combined with systemic chemotherapy as neo-adjuvant treatment of osteosarcoma of the extremity. Eur J Surg Oncol 2001; 27: 98–104.

    PubMed  CAS  Google Scholar 

  26. Ferrari S, Mercuri M, Picci P, et al. Nonmetastatic osteosarcoma of the extremity: results of a neoadjuvant chemotherapy protocol (IOR/OS-3) with high-dose methotrexate, intra-arterial or intravenous cisplatin, doxorubicin, and salvage chemotherapy based on histologic tumor response. Tumori 1999; 85: 458–64.

    PubMed  CAS  Google Scholar 

  27. Rha SY, Chung HC, Gong SJ, et al. Combined preoperative chemotherapy with intra-arterial cisplatin and continuous intravenous adriamycin for high grade osteosarcoma. Oncol Rep 1999; 6: 631–7.

    PubMed  CAS  Google Scholar 

  28. Winkler K, Bielack S, Delling G, et al. Effect of intra-arterial versus intravenous cisplatin in addition to systemic doxorubicin, high-dose methotrexate, and ifosfamide on histologic tumor response in osteosarcoma (Study COSS-86). Cancer 1990; 66: 1703–10.

    PubMed  CAS  Google Scholar 

  29. Abudu A, Sferopoulos NK, Tillman RM, Carter SR, Grimer RJ. The surgical treatment and outcome of pathological fractures in localised osteosarcoma. J Bone Joint Surg Br 1996; 78: 694–8.

    PubMed  CAS  Google Scholar 

  30. Scully SP, Temple HT, O’Keefe RJ, Mankin HJ, Gebhardt M. The surgical treatment of patients with osteosarcoma who sustain a pathologic fracture. Clin Orthop 1996; 324: 227–32.

    PubMed  Google Scholar 

  31. Bezwada HP, Granick MS, Long CD, et al. Soft-tissue complications of intra-arterial chemotherapy for extremity sarcomas. Ann Plast Surg 1998; 40: 382–7.

    PubMed  CAS  Google Scholar 

  32. Cheon JE, Kim IO, Kim WS, et al. Abdominal-wall myositis secondary to intra-arterial chemotherapy for femoral osteosarcoma. Pediatr Radiol 1999; 29: 546–8.

    PubMed  CAS  Google Scholar 

  33. Tsuchiya H, Morinaga T, Taki J, et al. Effect of myocutaneous inflammatory changes caused by intra-arterial chemotherapy on the outcome of patients who undergo limb-saving surgery. Cancer 2001; 91: 2447–53.

    PubMed  CAS  Google Scholar 

  34. Benjamin RS, Chawla SP, Carrasco CH, et al. Preoperative chemotherapy for osteosarcoma with intravenous adriamycin and intra-arterial cis-platinum. Ann Oncol 1992; 3: 3–6.

    Google Scholar 

  35. Quintana J, Beresi V, DelPozo H, et al. Intra-arterial cisplatin given prior to surgery in osteosarcoma: grade of necrosis and size of tumor as major prognostic factors. Am J Pediatr Hematol Oncol 1991; 13: 269–73.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute for Limb Preservation at Presbyterian/St. Luke’s Medical Center, Denver, Colorado

    Ross M. Wilkins MD, John W. Cullen MD, Brandt A. Jamroz MD, Patsy McGuire Cullen MS, CPNP, Kyle Fink MD, Sanford D. Peck MD, Sydney L. Stevens MD, Cynthia M. Kelly MD & Anne B. Camozzi BA

  2. The Children’s Hospital, Denver, Colorado

    Lorrie Odom MD

  3. The Institute for Limb Preservation at Presbyterian/St. Luke’s Medical Center, 1601 E. 19th Avenue, Suite 3250, Denver, CO, 80210

    Anne B. Camozzi BA

Authors
  1. Ross M. Wilkins MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. John W. Cullen MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lorrie Odom MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Brandt A. Jamroz MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Patsy McGuire Cullen MS, CPNP
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kyle Fink MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Sanford D. Peck MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Sydney L. Stevens MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Cynthia M. Kelly MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Anne B. Camozzi BA
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anne B. Camozzi BA.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wilkins, R.M., Cullen, J.W., Odom, L. et al. Superior Survival in Treatment of Primary Nonmetastatic Pediatric Osteosarcoma of the Extremity. Ann Surg Oncol 10, 498–507 (2003). https://doi.org/10.1245/ASO.2003.03.061

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1245/ASO.2003.03.061

Key Words

Search

Navigation